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Abstract  
Objective: To determine the prevalence of cerebral vascular abnormalities in various 
diagnostic subgroups of spontaneous subarachnoid hemorrhage (SAH) in a regional 
neurosurgical center in the modern era. 
Methods: Prospective data collection of 609 consecutive patients with spontaneous SAH in a 
3-year period (August 2010 to August 2013) was carried out. Patients were divided into three 
diagnostic subgroups: computed tomography (CT) positive for SAH; CT negative but 
positive cerebrospinal fluid (CSF) examination by spectrophotometry for SAH; CT negative 
for SAH and inconclusive CSF examination. All patients fit for intervention then underwent 
computed tomography angiography (CTA), with or without digital subtraction angiography 
(DSA) to identify vascular abnormalities for subsequent treatment.  
Results: Of the 609 identified patients, 554 were fit for further investigation and 
consideration of further intervention. 514 patients had confirmed SAH. 61.5% of patients 
were female. The mean age was 54.0 years. 390 patients (75.9%) showed vascular 
abnormalities on angiography. 438 patients (85.2%) with confirmed SAH were diagnosed on 
CT scan (Group 1) and 81.1% had detectable vascular abnormalities. 18.9% of patients with a 
positive CT scan had no identifiable cause of SAH. 76 patients (14.8%) with confirmed SAH 
had negative CT but positive LP (Group 2) and 46.1% of patients in this group had vascular 
abnormalities. 3 patients with inconclusive CSF examination had lesions requiring treatment. 
The median length of hospital stay in Group 1 patients was longer than the median length of 
hospital stay in Group 2 patients.   
Conclusions:  The frequency of vascular abnormalities in spontaneous SAH is lower than the 
traditionally quoted figure, which would have diagnostic and prognostic implications for 
patient management. 
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Introduction 
Spontaneous subarachnoid hemorrhage (SAH), makes up 2-9% of all strokes.1 Historical 
studies from the 1980s and 1990s showed that 80-85% of spontaneous SAH were secondary 
to ruptured aneurysm;2-5 with a mortality of 15% prior to hospitalisation.2 The in-hospital 
morbidity and mortality is usually due to re-bleeds and delayed ischemic neurological deficits 
(DIND). The mortality or morbidity from a re-bleed is 80%.6 The rate of DIND is 32%.7 
Other rarer causes of SAH include arterial dissection, cerebral arteriovenous malformation 
(AVM), and dural arteriovenous fistula (dAVF).8 
 
In 10-15% of patients with SAH no vascular abnormalities are shown on angiographic studies 
and this group is commonly termed angio-negative SAH.4, 9-12 Compared to patients with 
aneurysmal SAH, patients with angio-negative SAH generally have good outcome.13-15 
Patients with angio-negative SAH have lower rates of DIND compared to patients with 
aneurysmal SAH, 12 and a lower rate of recurrent hemorrhage.16 
 
SAH can be diagnosed using computed tomography (CT) or cerebrospinal fluid (CSF) 
examination. Modern CT scanners have a sensitivity of 100% in detecting SAH within 6 
hours after ictus, when the scan is interpreted by an experienced neuroradiologist.17 If CT 
brain is negative for SAH, CSF examination is required to detect SAH.18 To diagnose SAH 
via a CSF sample, an oxyhemoglobin (oxyHb) peak with a bilirubin shoulder must be 
detected in the CSF sample by spectrophotometry analysis. Bilirubin is derived from the 
degradation of oxyHb,19 which only occurs in vivo and not in vitro. CSF examination would 
be inconclusive when spectrophotometric detection of bilirubin in the CSF is impaired by 
large amounts of oxyHb, often as the result of fresh blood in the CSF.20, 21  
 
With increasing sensitivity of multi-detector CT scanners in detecting hemorrhage, and the 
increasing use of spectrophotometry to detect bilirubin in CSF, we hypothesized that more 
cases of spontaneous SAH are detected using these techniques. We want to determine the 
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prevalence of vascular abnormalities identified in patients with spontaneous SAH in our 
center and compare it to historical data.  
 
Methods 
Study design  
The Institute of Neurological Sciences, Glasgow, UK is a tertiary referral center for 
neurosurgery with a catchment population of about 2.6 million. The data was prospectively 
collected between Aug 2010 and 2013 from consecutive patients referred to the neurosurgical 
service with SAH, and retrospectively analyzed. The patients who were referred but not 
transferred for investigation or treatment were identified, usually due to a poor World 
Federation of Neurosurgical Societies (WFNS) grade.  
 
Study Population 
All patients with suspected SAH underwent CT scan as the first line investigation. CT 
negative patients underwent an LP to obtain CSF to test for bilirubin by spectrophotometry.  
An inconclusive CSF examination meant that the sample was non-diagnostic and the patient 
required further investigation to exclude SAH. Patients were stratified into 3 subgroups 
(Table 1). We grouped patients into Group 1, patients with SAH diagnosed by CT scan; 
Group 2, patients with SAH diagnosed by positive CSF examination for SAH; Group 3, 
patients with unconfirmed SAH due to negative CT scan and inconclusive CSF examination 
(oxyHb masking bilirubin peak).  
 
Imaging 
All initial CT imaging was performed at the referring hospitals. All patients accepted for 
further intervention underwent CT angiography (CTA) with digital three-dimensional 
reconstruction or CTA followed by four-vessel digital subtraction angiography (DSA). CTA 
was performed on 64 slice CT scanner. CTA scan parameters were: tube voltage 120kV, tube 
current 200mAs, CT dose index 38.7, slice thickness 0.625mm and anatomical coverage from 
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carina to vertex. DSA was performed on a biplane angiography unit with or without 3D 
reconstruction. 
 
Spectrophotometry 
The presence of an oxyhemoglobin absorption peak at 413-415 nm and a bilirubin shoulder at 
450-460 nm is diagnostic for SAH.22 A CSF sample was inconclusive for SAH if 
oxyhemoglobin was present in a high enough concentration to impair the detection of the 
bilirubin shoulder.  
 
Statistical analysis 
Data were analyzed using the statistical package of the social sciences (SPSS Version 21, 
IBM). Results were expressed as proportions (%). Fisher’s exact test, and Student’s t-test 
were used to compare parametric variables. Mann-Whitney test and Kruskal-Wallis test were 
used to analyze non-parametric variables. One way analysis of variance (ANOVA) was used 
to compare means across different groups. Chi squared test of association was used to 
analyze categorical variables. P values of <0.05 were considered statistically significant. 
 
Results  
During the study period 609 patients were referred to neurosurgery with a confirmed or 
suspected diagnosis of SAH. 554 patients were accepted for transfer and further investigation. 
55 patients were not transferred because, patients had either died or were in poor clinical 
condition at presentation and deemed not fit for intervention following discussion with local 
doctors and family. Figure 1 describes the flow of patients stratified into subgroups as shown 
in Table 1. 514 patients had confirmed SAH; 438 patients (85.2%) had SAH diagnosed on 
CT scan (Group 1). 76 patients (14.8%) had SAH diagnosed on CSF examination due to a 
negative CT (Group 2). 40 patients with unconfirmed SAH (Group 3) due to negative CT 
scan and inconclusive CSF examination.  
 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
Chong 
 
 7 
Patients with confirmed spontaneous SAH (Group 1 and Group 2 patients) 
The demographic of the study population is in Table 2. The mean age of patients with 
confirmed SAH was 54.0±12.9 years, 61.5% of patients were female. 390 patients (75.9%) 
with confirmed SAH showed one or more vascular abnormality. Of these 390 patients, 373 
patients (95.6%) showed one or more aneurysms. The rate of multiple aneurysms was 19.8% 
with 74 patients showing more than one aneurysm. The anatomical location of the aneurysms 
is shown in Table 3. Other vascular abnormalities were 12 AVMs (3 AVMs were associated 
with aneurysms), 3 vertebral dissections, 1 reversible cerebral vasoconstriction syndrome 
(RCVS), 1 dural arteriovenous fistula (dAVF), 1 moya-moya disease, 1 cerebral venous sinus 
thrombosis, 1 vertebral artery-basilar artery (VA-BA) fenestration. No vascular abnormalities 
were detected in 124 patients (24.1%) with confirmed SAH. In this cohort, all patients with 
negative CTA underwent DSA and 7 patients (1.4%) were found to have vascular 
abnormalities not described in the CTA. For patients with confirmed SAH, the median length 
of hospital stay was 13 days. 
 
Group 1 
438 patients (85.2% of patients with confirmed SAH) had a diagnosis of SAH with CT scan. 
The mean age of patients with SAH confirmed with CT scan was 54.7±12.7 years, 63.9% of 
patients were female. 76.5% of patients have good grade SAH (WFNS I-II). The median time 
from ictus to investigation was 0 days (interquartile range (IR) 0 to 1 day), with 69.5% 
(304/438) of patients admitted for investigations within 24 hours of ictus. In this cohort, only 
a small subset of patients (7.5%, 33/438) were investigated over 72 hours of ictus. The rate of 
vascular abnormality detection was 81.1% (355 patients) in Group 1 patients (Table 4). Of 
patients with vascular abnormalities, 340 patients (95.8%) have one or more aneurysms. 67 
patients (19.7%) had multiple aneurysms. Other vascular abnormalities were, 8 AVMs (1 
AVM associated with aneurysms), 3 vertebral dissections, 1 reversible cerebral 
vasoconstriction syndrome, 1 dAVF, 1 moya moya disease, 1 CVST, 1 VA-BA fenestration. 
After a first negative CTA or inconclusive CTA, 4 patients (1.0%) were found to have 
vascular abnormalities on DSA not described in the previous CTA; which included bilateral 
paraophthalmic aneurysms; dAVF; RCVS; anterior communicating artery aneurysm. In 
Group 1 patients that have cerebral vascular abnormalities, 85.0% of patients had 
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endovascular treatment to secure the ruptured aneurysms or vascular lesions, and 10.6% 
underwent surgical clipping. 1.5% of patients received no surgical intervention due to 
inoperable aneurysms or death after admission. (Table 5). The median length of hospital stay 
for Group 1 patients was 14 days (IR 10 to 24 days). At discharge, 78.0% of patients had 
good clinical outcome (modified Rankin Scale mRS 0-2).  
 
Group 2 
76 patients (14.8% of patients with confirmed SAH) had a negative CT scan and a positive 
CSF examination. The mean age of Group 2 patients was 49.9±13.0 years, 47.4% of patients 
were female. 98.6% of patients have good grade SAH (WFNS I-II). The median time from 
ictus to investigation was 3 days (IR 1 to 6 days), with only 15.8% (12/76) of patients 
investigated within 24 hours of ictus. 46.1% (35/76) of patients presented late and was 
investigated over 72 hours of ictus. The incidence of vascular abnormalities in Group 2 
patients was 46.1% (35 patients). 33 patients (94.3%) had one or more aneurysms. 26 patients 
(78.8%) had multiple aneurysms. 4 patients had AVMs (2 patients had AVM associated with 
aneurysms). The difference in the rate of vascular abnormality between Group 1 and Group 2 
patients was statistically significant (p<0.0001 on two-tailed Fisher’s Exact Test). After a 
first negative CTA or inconclusive CTA, 3 patients (3.9%) were found to have vascular 
abnormalities not described in the previous CTA. The vascular abnormalities identified by 
DSA were 2 patients with micro-AVM and 1 patient with small left ICA aneurysm. 77.14% 
had endovascular treatment to secure the ruptured aneurysms or vascular lesions, and 11.4% 
underwent surgical clipping. The median length of hospital stay for Group 2 patients was 7 
days (IR 4 to 11 days). 95.9% of Group 2 patients had good outcome at discharge (mRS 0-2).  
 
Rebleeding in Group 1 and Group 2 patients 
In total 30 patients (5.8%) had rebleeding. 29 patients (6.6%) in Group 1 experienced at least 
one rebleeding episode. In Group 1, 27 patients (6.2%) experienced one rebleeding episode 
and 2 patients (0.5%) experienced two rebleeding episodes. 1 patient (1.3%) in Group 2 
experienced one rebleed. 26 of the 30 patients that experienced rebleeding received treatment 
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to secure the ruptured aneurysms, and the median time from ictus to treatment was 3 days (IR 
1 to 6 days). The remaining 4 patients died prior to receiving any intervention. 
 
Group 3 
There were 40 patients with a negative CT scan and an inconclusive CSF examination. The 
mean age of Group 3 patients was 44.1±12.5 years. 55.0% of patients were female. The 
median time from ictus to investigation was 3 days (IR 1 to 5 days), with 17.5% (7/40) of 
patients investigated within 24 hours of ictus. 42.5% (17/40) of patients presented late and 
was investigated over 72 hours of ictus. 3 patients had aneurysms detected on CTA. 1 patient 
underwent surgical clipping of the aneurysm and 2 patients were treated using endovascular 
techniques. 37 patients had no identifiable vascular abnormalities, and 11 patients had DSA 
after a first negative or inconclusive CTA and no new vascular abnormality was found. The 
median length of hospital stay was 4 days in Group 3 patients (IR 1 to 7 days). No patients 
were readmitted within 6 months of discharge to imply missed vascular anomalies. The 
median length of hospital stay across the 3 groups were all statistically significant (P=0.000). 
100% of Group 3 patients had good mRS at discharge and the proportion of patients with 
good mRS across the 3 groups were significantly different (P=0.000). 
 
Discussion  
The overall rate of identification of vascular abnormalities in patients with confirmed SAH 
(Groups 1 and 2) in our study is 75.9% (Figure 2). This is lower than the traditionally quoted 
value of 80-85%.3 Importantly, 24.1% of patients in our study had SAH with no detectable 
vascular abnormalities. This is higher than the 10-15% that is traditionally quoted as the 
proportion of angio-negative SAH.4, 9-11, 23 This implies that 1 in 4 patients with confirmed 
SAH could potentially have an excellent prognosis compared to the previously held 
proportion of 1 in 8 patients. We postulate that the higher proportion of angio–negative SAH 
in our study is due to several factors, including new generation CT scanners better at 
detecting low or small blood load SAH. The usage of spectrophotometry instead of 
xanthochromia might translate into higher sensitivity for detecting SAH24, furthermore raised 
CSF bilirubin is not specific for SAH and can be raised in other medical conditions including 
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meningitis.25  
 
If we combine confirmed SAH patients and Group 3 patients the rate of identification of 
vascular abnormalities is even lower at 70.9%. 
 
The timing from ictus to hospital presentation, and therefore medical investigations for SAH 
of the various subgroups are different. For group 1 patients, 70% of patients were admitted 
within 24 hours of ictus, while only 16% and 18% of group 2 and group 3 respectively 
presented early. Patients in Group 2 had a significantly lower rate (46.1%) of identification of 
cerebral vascular abnormalities compared to patients in Group 1 (81.1%). Two recent studies 
from the last 5 years by Chalouhi et al.26 and Bakker et al.27, also showed that the rate of 
vascular abnormality detection for Group 2 patients was 45.7% and 43% respectively. Group 
2 patients had a higher proportion of WFNS I-II SAH; required less surgical treatment and 
had better mRS at discharge compared to Group 1 patients (P<0.05). We showed here that 
patients with SAH confirmed by positive CSF examination (Group 2 patients) had better 
clinical outcome than patients with SAH confirmed by CT scan.  
 
Questions remained regarding the pickup rate of vascular abnormality after a negative CTA. 
The common practice is to perform a DSA on patients with negative CTA. Our study found 
that the pickup rate of vascular abnormalities is low on DSA after a negative CTA. 1.4% of 
patients with confirmed SAH and negative CTA had positive findings on subsequent DSA, 
and no further yield was detected for group 3 patients. At first glance, it might appear that 
group 2 patients had a higher rate (3.9%) of vascular anomalies that were not detected on 
CTA compared to group 1 (1%), however if we look at the absolute number, 4 patients from 
group 1 compared to 3 patients in group 2 had subsequent vascular anomalies detected after 
DSA. Such number is so small, and when calculating the percentages, due to the denominator, 
despite the differences, this finding is not statistically significant.  
 
19.8% of patients with aneurysms had multiple intracranial aneurysms, and this agreed with 
multiple large studies including ISAT and BRAT.28,29 In this study, most aneurysms were in 
the anterior circulation and this is in keeping with the published literature.28,29 Treatment 
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strategy may differ based on the configuration and location of the aneurysm, and the clinical 
presentation.29-32  
 
In patients with unconfirmed SAH (Group 3), 7% of patients were found to have vascular 
abnormality after CTA, with no further yield despite DSA. Prior to 2010, we performed 
delayed DSA and MRI after negative investigations (CTA +/- DSA) for group 3 patients, but 
departmental audits showed that no further vascular anomalies were picked up despite that 
practice. Therefore, we no longer subject our group 3 patients to the delayed invasive DSA 
investigations, but we follow them up clinically. None of the group 3 patients were 
readmitted within 6 months of discharge to imply missed vascular anomalies. 
 
 Group 3 patients do better than Group 1 and Group 2 patients. This is reflected in the 
statistically significant lower median length of hospital stay and a higher proportion of 
patients with good mRS at discharge.  However we are aware of the limitation with the small 
sample size in this group to draw any definitive conclusion, although the rate of vascular 
abnormality might be just slightly higher to the incidence of cerebral aneurysm in the 
background population.33 Potentially a group of patients with suspected SAH with a negative 
CTA can be discharged sooner without the delay of waiting for a DSA, thereby reducing 
hospital stay. A good history and a careful balancing of the risk and benefits of further 
investigation for patients with inconclusive LP is essential. 
 
Despite the study from a single regional neurosurgical center, the large study sample size of 
609 patients prospectively collected over a 3-year period, we believe would ensure the 
validity of our results. 55 patients were excluded from analysis and investigation due to poor 
grade SAH or death and were not transferred to the department. Even if we assume that all 
these patients have underlying cerebral aneurysms, the rate of vascular anomalies for patients 
with confirmed SAH would be 78.2% (445/569), which is a difference of 2.3% from the 
75.9% (390/514) quoted in our paper and would not alter our conclusion.  
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Conclusions 
This contemporary study in a large UK population challenges the historic studies with 
regards to the frequency of identification of vascular abnormalities following spontaneous 
SAH. Our data shows that the frequency of identification of vascular abnormalities is lower 
when compared to historical data from the 1980s and 1990s, which would have diagnostic 
and prognostic implications for patient management. Furthermore, patients with SAH 
diagnosed by CT are more likely to have a lesion requiring treatment than those diagnosed by 
CSF examination.  
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Appendix 
 
Figure 1: Flowchart showing the study population 
Figure 2: Rate of vascular abnormalities in the different diagnostic subgroups.  
 
 
Table 1: Stratification of patient subgroups. 
 
Table 2: Comparative table of the patient demographics, admission grade, treatment, and 
outcome for the 3 groups of patients. Age (mean±SD) and gender distribution of the study 
population. * statistically significant difference (P<0.05) 
 
Table 3. Overall frequency and proportion of anatomical sites of aneurysms  
 
Table 4: Incidence of vascular abnormality in various diagnostic subgroups of SAH 
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Group  Criteria 
1 Confirmed SAH. CT scan positive for SAH.  
2 Confirmed SAH. CT scan negative for SAH, bilirubin in CSF.  
3 Unconfirmed SAH. CT scan negative for SAH, inconclusive CSF result.  
 
Table 1: Stratification of patient subgroups. 
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 Confirmed SAH Group 1 Group 2 Group 3 P values 
Number of Patients 514 438 76 40  
Mean Age (years) 54.0±12.9 54.7±12.7* 49.9±13.0* 44.1±12.5* 0.000 
Females (%) 61.5 63.9* 47.4* 55.0* 0.017 
WFNS Admission Grade (%)      
WFNS I-II  76.1 76.5* 98.6* NA 0.000 
WFNS III-IV  23.9 23.5 1.4 NA  
Median hospital stay (Days) 13 14* 7* 4* 0.000 
mRS at discharge (%)      
mRS  0-2 (%) 80.6 78.0* 95.9* 100* 0.000 
mRS 3-6 (%) 19.4 22.0 4.1 0  
 
Table 2: Comparative table of the patient demographics, admission grade, treatment, and outcome for the 3 groups of patients. Age 
(mean±SD) and gender distribution of the study population. * statistically significant difference (P<0.05) 
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Aneurysm Proportion (%) 
ACA 5.2 
ACom 24.9 
ICA 15.7 
MCA 20.7 
PCom 21.1 
Anterior 87.6 
PCA 1.0 
Basilar 5.0 
SCA 2.2 
PICA 3.4 
AICA 0.4 
Vertebral 0.4 
Posterior 12.4 
 
Table 3. Overall frequency and proportion of anatomical sites of aneurysms  
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 Confirmed SAH  Group 1 Group 2 Group 3 P values 
Rate of 
vascular 
abnormalities 
75.9% 81.1% 46.1% 7.5% 0.0001 
 
Table 4: Incidence of vascular abnormality in various diagnostic subgroups of SAH 
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Figure 1: Flowchart showing the study population 
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Figure 2: Rate of vascular abnormalities in the different diagnostic subgroups.  
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Highlights  
• The rate of intracranial vascular abnormality in patients with confirmed SAH in the 
modern era is lower than previous studies from the 1980s and 1990s.  
• This finding could have diagnostic and prognostic implications for patients’ management. 
• Patients with subarachnoid haemorrhage diagnosed by CT are more likely to have an 
underlying vascular lesion than those diagnosed by LP.  
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Abbreviation list:  
ACA – Anterior Cerebral Artery 
AComA – Anterior Communicating Artery 
AICA – Anterior Inferior Cerebellar Artery 
AVM – Arteriovenous malformation 
BRAT – Barrow Ruptured Aneurysm Trial 
CSF – Cerebrospinal Fluid 
CT – Computed Tomography 
CTA – CT Angiography 
dAVF – dural Arteriovenous Fistula 
DNID – Delayed Neurological Ischemic Disorder 
DSA – Digital Subtraction Angiography 
ICA – Internal Carotid Artery 
INS – Institute of Neurological Sciences 
ISAT – International Subarachnoid Aneurysm Trial 
LP – Lumbar Puncture 
MCA – Middle Cerebral Artery 
oxyHb – oxyhemoglobin 
PCA – Posterior Cerebral Artery 
PComA – Posterior Communicating Artery 
PICA – Posterior Inferior Cerebellar Artery 
RCVS – Reversible Cerebral Vasoconstriction Syndrome 
SAH - Subarachnoid Hemorrhage  
SCA – Superior Cerebellar Artery 
SPSS – Statistical Package of the Social Sciences 
VA-BA – Vertebral Artery-Basilar Artery 
WFNS – World Federation of Neurosurgical Societies 
